Nordic Nanovector in full capitulation mode - bottom near?After a stellar 2016 (nanoinvestors.wordpress.com), things have been going downhill for the Nordic Nanovector stock.
After recently giving a sell signal by crashing through a triple bottom at NOK 68, investors are now looking to the NOK 40 line to see if it can provide support for a bounce.
Oncology
One possible path for CLVSA few thoughts on CLVS. May not pan out, but this is a bullish scenario.
Reasons the bull scenario could play out from a technical standpoint:
1. Move up to $99 was a clear 5 waves. It looks to have recently completed the ABC correction into a perfect golden pocket 61.8 to 65% retracement.
2. Wave C was an ending diagonal. CLVS has broken out of the diagonal to the upside after a throw over to the downside (a common occurrence in diagonals).
3. Wave 1 up of the new trend has already retraced about 50%. If it gets to the $53-54 range soon, that will make a 61.8% retracement of wave 1 up.
Aggressive traders might be looking to buy the drop to the $53 range hoping the above scenario is correct.
More conservative traders might wait for it to break the high of wave 1 around $63 for confirmation of a new uptrend.
I have no position at this time, but will be watching closely and may enter a position in the future.
Obviously, the bear scenario (which does not really need much chart elaboration) would be that the current downward movement continues to the lower trendline, possibly testing the low $40's in the near future.
BIOC Cancer Diagnostics Eliminates Biopsies with Blood TestBlood diagnostic OncoCEE-BR was used by Columbia University College of Physicians and Surgeons in New York City to aid cancer patients' diagnosis. Involved biopsies are no longer required, cancer can be detected with a simple blood test. The chart has strong bullish divergence, has just made a breakout with an initial target around 4 dollars.
